Russell H. Swerdlow - Publications

Molecular & Integrative Physiology University of Kansas, Lawrence, KS, United States 
Physiology Biology, Neuroscience Biology, Cell Biology, Molecular Biology

212 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 McInerney TW, Fulton-Howard B, Patterson C, Paliwal D, Jermiin LS, Patel HR, Pa J, Swerdlow RH, Goate A, Easteal S, Andrews SJ. A globally diverse reference alignment and panel for imputation of mitochondrial DNA variants. Bmc Bioinformatics. 22: 417. PMID 34470617 DOI: 10.1186/s12859-021-04337-8  1
2021 Wilkins HM, Swerdlow RH. Mitochondrial links between brain aging and Alzheimer's disease. Translational Neurodegeneration. 10: 33. PMID 34465385 DOI: 10.1186/s40035-021-00261-2  1
2021 Pope CA, Wilkins HM, Swerdlow RH, Wolfe MS. Mutations in the Amyloid-β Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-β Peptide. Journal of Alzheimer's Disease : Jad. PMID 34366346 DOI: 10.3233/JAD-210366  1
2021 Sharma P, Montgomery RN, Graves RS, Meyer K, Hunt SL, Vidoni ED, Mahnken JD, Swerdlow RH, Burns JM, Mudaranthakam DP. CONSENSUS: a Shiny application of dementia evaluation and reporting for the KU ADC longitudinal Clinical Cohort database. Jamia Open. 4: ooab060. PMID 34350395 DOI: 10.1093/jamiaopen/ooab060  1
2021 Cunnane SC, Sieber CC, Swerdlow RH, Cruz-Jentoft AJ. Mild cognitive impairment: when nutrition helps brain energy rescue-a report from the EuGMS 2020 Congress. European Geriatric Medicine. PMID 34227053 DOI: 10.1007/s41999-021-00534-z  0.04
2021 Tungtur SK, Wilkins HM, Rogers RS, Badawi Y, Sage JM, Agbas A, Jawdat O, Barohn RJ, Swerdlow RH, Nishimune H. Oxaloacetate treatment preserves motor function in SOD1 mice and normalizes select neuroinflammation-related parameters in the spinal cord. Scientific Reports. 11: 11051. PMID 34040085 DOI: 10.1038/s41598-021-90438-6  1
2021 Wilkins HM, Wang X, Menta BW, Koppel SJ, Bothwell R, Becker AM, Anderson H, Schwartz E, Pei D, Yellapu NK, Chalise P, Gouvion CM, Haeri M, Burns JM, Swerdlow RH. Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE ε4-carriers. Aging Cell. e13356. PMID 33939248 DOI: 10.1111/acel.13356  1
2021 Swerdlow RH, de Leon MJ, Marcus DL. Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer's Disease Subjects. Journal of Alzheimer's Disease Reports. 5: 135-141. PMID 33782666 DOI: 10.3233/ADR-210002  0.08
2021 Koppel SJ, Pei D, Wilkins HM, Weidling IW, Wang X, Menta BW, Perez-Ortiz J, Kalani A, Manley S, Novikova L, Koestler DC, Swerdlow RH. A Ketogenic Diet Differentially Affects Neuron And Astrocyte Transcription. Journal of Neurochemistry. PMID 33539571 DOI: 10.1111/jnc.15313  1
2020 Flax J, Wilkins HM, Miller R, Griffith S, Cork GK, Qiang A, Thompson J, Swerdlow RH, Slawson C. OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids. Journal of Alzheimer's Disease : Jad. PMID 33285636 DOI: 10.3233/JAD-200996  1
2020 Kunkle BW, Schmidt M, Klein HU, Naj AC, Hamilton-Nelson KL, Larson EB, Evans DA, De Jager PL, Crane PK, Buxbaum JD, Ertekin-Taner N, Barnes LL, Fallin MD, Manly JJ, Go RCP, ... ... Swerdlow RH, et al. Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. Jama Neurology. PMID 33074286 DOI: 10.1001/jamaneurol.2020.3536  1
2020 Wang X, Weidling I, Koppel S, Menta B, Perez Ortiz J, Kalani A, Wilkins HM, Swerdlow RH. Detection of Mitochondria-Pertinent Components in Exosomes. Mitochondrion. PMID 32980480 DOI: 10.1016/j.mito.2020.09.006  1
2020 Swerdlow RH. The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease. International Review of Neurobiology. 154: 207-233. PMID 32739005 DOI: 10.1016/Bs.Irn.2020.01.008  0.01
2020 Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, ... ... Swerdlow RH, et al. Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32715609 DOI: 10.1002/Alz.12156  1
2020 Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF, Bergersen LH, Brinton RD, de la Monte S, Eckert A, Harvey J, Jeggo R, Jhamandas JH, Kann O, ... ... Swerdlow RH, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nature Reviews. Drug Discovery. PMID 32709961 DOI: 10.1038/S41573-020-0072-X  1
2020 Swerdlow RH, Hui D, Chalise P, Sharma P, Wang X, Andrews SJ, Pa J, Mahnken JD, Morris J, Wilkins HM, Burns JM, Michaelis ML, Michaelis EK. Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32543785 DOI: 10.1002/Alz.12119  1
2020 Weidling IW, Swerdlow RH. Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis. Experimental Neurology. 330: 113321. PMID 32339611 DOI: 10.1016/J.Expneurol.2020.113321  1
2020 Swerdlow RH. Mitochondria in Alzheimer brains: A PET project shows complex changes. Neurology. PMID 32139503 DOI: 10.1212/Wnl.0000000000009236  0.01
2020 Yan T, Liang J, Gao J, Wang L, Fujioka H, Zhu X, Wang X. FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nature Communications. 11: 411. PMID 31964863 DOI: 10.1038/S41467-019-13962-0  0.8
2019 Kundu S, Lukemire J, Wang Y, Guo Y. A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer's Disease Data. Scientific Reports. 9: 19589. PMID 31863067 DOI: 10.1038/S41598-019-55818-Z  0.68
2019 Andrews SJ, Fulton-Howard B, Patterson C, McFall GP, Gross A, Michaelis EK, Goate A, Swerdlow RH, Pa J. Mitonuclear interactions influence Alzheimer's disease risk. Neurobiology of Aging. PMID 31784277 DOI: 10.1016/J.Neurobiolaging.2019.09.007  1
2019 Taylor MK, Swerdlow RH, Sullivan DK. Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality. Nutrients. 11. PMID 31443216 DOI: 10.3390/Nu11081910  1
2019 Pa J, Andrews SJ, Swerdlow RH. Mitochondria and Alzheimer's: Is PTCD1 the Smoking Gun? Trends in Neurosciences. PMID 31421943 DOI: 10.1016/J.Tins.2019.08.003  1
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Swerdlow RH, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7  1
2019 Tian J, Guo L, Sui S, Driskill C, Phensy A, Wang Q, Gauba E, Zigman JM, Swerdlow RH, Kroener S, Du H. Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease. Science Translational Medicine. 11. PMID 31413143 DOI: 10.1126/Scitranslmed.Aav6278  0.52
2019 Watts A, Wilkins HM, Michaelis E, Swerdlow RH. TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes. Journal of Alzheimer's Disease : Jad. PMID 31322569 DOI: 10.3233/Jad-190293  1
2019 Reddy PH, Swerdlow RH, Culberson J, Kang D, Mitchell TL, Smith Q, Suneja S, Ory MG, Kumar S, Vijayan M, Morsy A, Arandia G, Lawrence JJ, George E, Oliver D, et al. Current Status of Healthy Aging and Dementia Research: A Symposium Summary. Journal of Alzheimer's Disease : Jad. PMID 31104030 DOI: 10.3233/Jad-190252  0.12
2019 Weidling I, Swerdlow RH. Mitochondrial Dysfunction and Stress Responses in Alzheimer's Disease. Biology. 8. PMID 31083585 DOI: 10.3390/Biology8020039  1
2019 Taylor MK, Swerdlow RH, Burns JM, Sullivan DK. An Experimental Ketogenic Diet for Alzheimer Disease Was Nutritionally Dense and Rich in Vegetables and Avocado. Current Developments in Nutrition. 3: nzz003. PMID 30931426 DOI: 10.1093/cdn/nzz003  1
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Swerdlow RH, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2  1
2019 Ji Y, Wang X, Kalicki C, Menta BW, Baumgardner M, Koppel SJ, Weidling IW, Perez-Ortiz J, Wilkins HM, Swerdlow RH. Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena. Journal of Alzheimer's Disease : Jad. PMID 30714956 DOI: 10.3233/Jad-180820  1
2019 Perez Ortiz JM, Swerdlow RH. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities. British Journal of Pharmacology. PMID 30675901 DOI: 10.1111/bph.14585  0.4
2019 Moran C, Beare R, Wang W, Callisaya M, Srikanth V. Type 2 diabetes mellitus, brain atrophy, and cognitive decline. Neurology. PMID 30674592 DOI: 10.1212/Wnl.0000000000006955  0.32
2019 Morris JK, McCoin CS, Fuller KNZ, John CS, Wilkins HM, Wang X, Mahnken JD, Swerdlow RH, Thyfault JP. P1-197: Skeletal Muscle Mitochondrial Function In Cognitively Healthy Elderly And Mci Subjects Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.752  1
2018 Song H, Chen M, Chen C, Cui J, Johnson CE, Cheng J, Wang X, Swerdlow R, DePalma R, Xia W, Gu Z. Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction following Low-Intensity Primary Blast Exposure. Journal of Neurotrauma. PMID 30484371 DOI: 10.1089/Neu.2018.6114  1
2018 Kumar RP, Ray S, Home P, Saha B, Bhattacharya B, Wilkins HM, Chavan H, Ganguly A, Milano-Foster J, Paul A, Krishnamurthy P, Swerdlow RH, Paul S. Regulation of energy metabolism during early mammalian development: TEAD4 controls mitochondrial transcription. Development (Cambridge, England). PMID 30201685 DOI: 10.1242/Dev.162644  1
2018 Statland JM, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, Nations S, Mitsumoto H, Fernandes JA, Saperstein D, Hayat G, Herbelin L, Karam C, Katz J, Wilkins HM, ... ... Swerdlow RH, et al. Rasagiline for Amyotrophic Lateral Sclerosis: a Randomized Controlled Trial. Muscle & Nerve. PMID 30192007 DOI: 10.1002/Mus.26335  1
2018 Menta BW, Swerdlow RH. An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease. Neurochemical Research. PMID 30084096 DOI: 10.1007/S11064-018-2603-Y  1
2018 Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 28-36. PMID 29955649 DOI: 10.1016/J.Trci.2017.11.002  1
2018 Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Swerdlow RH, Diaz Brinton R. Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. Plos One. 13: e0193314. PMID 29447296 DOI: 10.1371/Journal.Pone.0193314  1
2018 Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP, Weiner MW, Aisen P, Weiner M, Aisen P, ... ... Swerdlow RH, et al. 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. PMID 29389750 DOI: 10.1097/Aln.0000000000002103  1
2018 Andrews SJ, Swerdlow RH, McInerney T, Fulton-Howard B, Gross AL, McFall GP, Patterson C, Goate AM, Michaelis EK, Pa J, Initiative ADN. P4-244: Mitochondrial Haplogroups And A Nuclear Encoded Mitochondrial Polygenic Risk Score Interact To Influence Dementia Risk Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.065  1
2017 Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bolaños JP, Culmsee C, Dawson VL, Deshmukh M, Duchen MR, Düssmann H, Fiskum G, Galindo MF, Hardingham GE, Hardwick JM, ... ... Swerdlow RH, et al. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death and Differentiation. PMID 29229998 DOI: 10.1038/S41418-017-0020-4  1
2017 Du L, Liu K, Yao X, Yan J, Risacher SL, Han J, Guo L, Saykin AJ, Shen L. Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty. Scientific Reports. 7: 14052. PMID 29070790 DOI: 10.1038/S41598-017-13930-Y  0.68
2017 Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, Burns JM. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. The American Journal of Clinical Nutrition. PMID 29070566 DOI: 10.3945/Ajcn.117.162263  1
2017 Swerdlow RH. Mitochondria and Mitochondrial Cascades in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29036828 DOI: 10.3233/Jad-170585  0.01
2017 Mosconi L, Berti V, Guyara-Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Swerdlow RH, Brinton RD. Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. Plos One. 12: e0185926. PMID 29016679 DOI: 10.1371/Journal.Pone.0185926  1
2017 Ma E, Chen P, Wilkins HM, Wang T, Swerdlow RH, Chen Q. Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis. Free Radical Biology & Medicine. PMID 28916476 DOI: 10.1016/J.Freeradbiomed.2017.09.008  1
2017 Wang X, Zhang Q, Bao R, Zhang N, Wang Y, Polo-Parada L, Tarim A, Alemifar A, Han X, Wilkins HM, Swerdlow RH, Wang X, Ding S. Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death. Cell Reports. 20: 2184-2200. PMID 28854367 DOI: 10.1016/J.Celrep.2017.08.022  1
2017 Singanamalli A, Wang H, Madabhushi A. Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features. Scientific Reports. 7: 8137. PMID 28811553 DOI: 10.1038/S41598-017-03925-0  0.36
2017 Guilford BL, Ryals JM, Lezi E, Swerdlow RH, Wright DE. Dorsal Root Ganglia Mitochondrial Biochemical Changes in Non-diabetic and Streptozotocin-Induced Diabetic Mice Fed with a Standard or High-Fat Diet. Journal of Neurology and Neuroscience. 8. PMID 28775932 DOI: 10.21767/2171-6625.1000180  1
2017 Tan EP, McGreal SR, Graw S, Tessman R, Koppel SJ, Dhakal P, Zhang Z, Machacek M, Zachara NE, Koestler DC, Peterson KR, Thyfault JP, Swerdlow RH, Krishnamurthy P, DiTacchio L, et al. Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism. The Journal of Biological Chemistry. PMID 28739801 DOI: 10.1074/Jbc.M117.797944  1
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Swerdlow RH, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  1
2017 Wilkins HM, Mahnken JD, Welch P, Bothwell R, Koppel S, Jackson RL, Burns JM, Swerdlow RH. A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial. Journal of Alzheimer's Disease : Jad. PMID 28598847 DOI: 10.3233/Jad-170077  1
2017 Koppel SJ, Swerdlow RH. Neuroketotherapeutics: A modern review of a century-old therapy. Neurochemistry International. PMID 28579059 DOI: 10.1016/J.Neuint.2017.05.019  1
2017 Hutfles LJ, Wilkins HM, Koppel SJ, Weidling IW, Selfridge JE, Tan E, Thyfault JP, Slawson C, Fenton AW, Zhu H, Swerdlow RH. A Bioenergetics Systems Evaluation of Ketogenic Diet Liver Effects. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme. PMID 28514599 DOI: 10.1139/Apnm-2017-0068  1
2017 Wilkins HM, Weidling IW, Ji Y, Swerdlow RH. Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration. Frontiers in Immunology. 8: 508. PMID 28491064 DOI: 10.3389/Fimmu.2017.00508  1
2017 Wilkins HM, Koppel SJ, Bothwell R, Mahnken J, Burns JM, Swerdlow RH. Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients. Redox Biology. 12: 828-832. PMID 28448944 DOI: 10.1016/J.Redox.2017.04.010  1
2017 Hao X, Li C, Du L, Yao X, Yan J, Risacher SL, Saykin AJ, Shen L, Zhang D. Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease. Scientific Reports. 7: 44272. PMID 28291242 DOI: 10.1038/Srep44272  0.48
2017 Park JY, Na HK, Kim S, Kim H, Kim HJ, Seo SW, Na DL, Han CE, Seong JK. Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns. Scientific Reports. 7: 43270. PMID 28276464 DOI: 10.1038/Srep43270  0.4
2017 Swerdlow RH, Koppel S, Weidling I, Hayley C, Ji Y, Wilkins HM. Mitochondria, Cybrids, Aging, and Alzheimer's Disease. Progress in Molecular Biology and Translational Science. 146: 259-302. PMID 28253988 DOI: 10.1016/Bs.Pmbts.2016.12.017  1
2017 Morris JK, Vidoni ED, Johnson DK, Van Sciver A, Mahnken JD, Honea RA, Wilkins HM, Brooks WM, Billinger SA, Swerdlow RH, Burns JM. Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial. Plos One. 12: e0170547. PMID 28187125 DOI: 10.1371/Journal.Pone.0170547  1
2017 Chavan H, Christudoss P, Mickey K, Tessman R, Ni HM, Swerdlow R, Krishnamurthy P. Arsenite Effects on Mitochondrial Bioenergetics in Human and Mouse Primary Hepatocytes Follow a Nonlinear Dose Response. Oxidative Medicine and Cellular Longevity. 2017: 9251303. PMID 28163822 DOI: 10.1155/2017/9251303  1
2017 Huang M, Yang W, Feng Q, Chen W. Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease. Scientific Reports. 7: 39880. PMID 28079104 DOI: 10.1038/Srep39880  0.68
2016 Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BT. Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 27702899 DOI: 10.1073/Pnas.1611073113  0.32
2016 Yu Q, Fang D, Swerdlow RH, Yu H, Chen JX, Yan SS. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells. Journal of Alzheimer's Disease : Jad. PMID 27567872 DOI: 10.3233/Jad-160532  1
2016 Wilkins HM, Koppel SJ, Weidling IW, Roy N, Ryan LN, Stanford JA, Swerdlow RH. Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 27562848 DOI: 10.1007/S11481-016-9704-7  1
2016 Wilkins HM, Swerdlow RH. Amyloid Precursor Protein Processing and Bioenergetics. Brain Research Bulletin. PMID 27545490 DOI: 10.1016/J.Brainresbull.2016.08.009  1
2016 Morris JK, Vidoni ED, Wilkins HM, Archer AE, Burns NC, Karcher RT, Graves RS, Swerdlow RH, Thyfault JP, Burns JM. Impaired fasting glucose is associated with increased regional cerebral amyloid. Neurobiology of Aging. 44: 138-42. PMID 27318141 DOI: 10.1016/J.Neurobiolaging.2016.04.017  1
2016 Liu H, Zhou X, Jiang H, He H, Liu X. A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer's disease. Scientific Reports. 6: 26712. PMID 27273250 DOI: 10.1038/srep26712  0.76
2016 Tan L, Wang HF, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT. Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. Scientific Reports. 6: 26027. PMID 27229352 DOI: 10.1038/srep26027  0.64
2016 He M, Singh P, Cheng S, Zhang Q, Peng W, Ding X, Li L, Liu J, Premont RT, Morgan D, Burns JM, Swerdlow RH, Suo WZ. GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability. Scientific Reports. 6: 26116. PMID 27193825 DOI: 10.1038/Srep26116  1
2016 Stroh MA, Winter MK, Swerdlow RH, McCarson KE, Zhu H. Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice. Metabolic Brain Disease. PMID 27188291 DOI: 10.1007/S11011-016-9834-X  1
2016 Xu W, Wang HF, Tan L, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT. The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum. Scientific Reports. 6: 24480. PMID 27117083 DOI: 10.1038/srep24480  0.6
2016 Swerdlow RH, Bothwell R, Hutfles L, Burns JM, Reed GA. Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects. Bba Clinical. 5: 120-3. PMID 27051598 DOI: 10.1016/J.Bbacli.2016.03.005  1
2016 Swerdlow RH. Rare ABCA7 variants in Alzheimer disease: Guilt by association. Neurology. PMID 27037231 DOI: 10.1212/Wnl.0000000000002630  0.01
2016 Weidling I, Swerdlow RH. The ABCD's of 5'-adenosine monophosphate-activated protein kinase and adrenoleukodystrophy. Journal of Neurochemistry. PMID 26990533 DOI: 10.1111/Jnc.13594  1
2016 Swerdlow RH. Bioenergetics and metabolism: a bench to bedside perspective. Journal of Neurochemistry. PMID 26968700 DOI: 10.1111/Jnc.13509  0.01
2016 Wilkins HM, Koppel S, Carl SM, Ramanujan S, Weidling I, Michaelis ML, Michaelis EK, Swerdlow RH. Oxaloacetate Enhances Neuronal Cell Bioenergetic Fluxes and Infrastructure. Journal of Neurochemistry. PMID 26811028 DOI: 10.1111/Jnc.13545  1
2016 E L, Swerdlow RH. Lactate's effect on human neuroblastoma cell bioenergetic fluxes. Biochemical Pharmacology. 99: 88-100. PMID 26592660 DOI: 10.1016/J.Bcp.2015.11.002  1
2016 Wilkins HM, Swerdlow RH. Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease. Current Topics in Medicinal Chemistry. 16: 849-57. PMID 26311426 DOI: 10.2174/1568026615666150827095102  1
2015 Graves RS, Mahnken JD, Swerdlow RH, Burns JM, Price C, Amstein B, Hunt SL, Brown L, Adagarla B, Vidoni ED. Open-source, Rapid Reporting of Dementia Evaluations. Journal of Registry Management. 42: 111-114. PMID 26779306  1
2015 Swerdlow RH. Mitochondrial Manipulation and the Quest for Alzheimer's Treatments. Ebiomedicine. 2: 276-7. PMID 26137567 DOI: 10.1016/J.Ebiom.2015.03.017  0.01
2015 Macchi Z, Wang Y, Moore D, Katz J, Saperstein D, Walk D, Simpson E, Genge A, Bertorini T, Fernandes JA, Swenson A, Elman L, Dimachkie M, Herbelin L, Miller J, ... ... Swerdlow RH, et al. A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 25832828 DOI: 10.3109/21678421.2015.1026826  1
2015 Wilkins HM, Swerdlow RH. TNFα in cerebral ischemia: another stroke against you? Journal of Neurochemistry. 132: 369-72. PMID 25656781 DOI: 10.1111/Jnc.13028  1
2015 Arduíno DM, Esteves AR, Swerdlow RH, Cardoso SM. A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease. Methods in Molecular Biology (Clifton, N.J.). 1265: 415-24. PMID 25634293 DOI: 10.1007/978-1-4939-2288-8_31  1
2015 Wilkins HM, Carl SM, Weber SG, Ramanujan SA, Festoff BW, Linseman DA, Swerdlow RH. Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. Journal of Alzheimer's Disease : Jad. 45: 305-18. PMID 25537010 DOI: 10.3233/Jad-142334  1
2015 Selfridge JE, Wilkins HM, E L, Carl SM, Koppel S, Funk E, Fields T, Lu J, Tang EP, Slawson C, Wang W, Zhu H, Swerdlow RH. Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. Journal of Bioenergetics and Biomembranes. 47: 1-11. PMID 25104046 DOI: 10.1007/S10863-014-9570-Z  1
2014 Wilkins HM, Carl SM, Swerdlow RH. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Redox Biology. 2: 619-631. PMID 25460729 DOI: 10.1016/J.Redox.2014.03.006  1
2014 Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH. Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Frontiers in Aging Neuroscience. 6: 311. PMID 25426068 DOI: 10.3389/Fnagi.2014.00311  1
2014 Swerdlow RH. Comment: BDNF, fitness, and the brain. Neurology. 83: 1351. PMID 25186860 DOI: 10.1212/Wnl.0000000000000869  0.01
2014 Mahato B, Home P, Rajendran G, Paul A, Saha B, Ganguly A, Ray S, Roy N, Swerdlow RH, Paul S. Regulation of mitochondrial function and cellular energy metabolism by protein kinase C-λ/ι: a novel mode of balancing pluripotency. Stem Cells (Dayton, Ohio). 32: 2880-92. PMID 25142417 DOI: 10.1002/Stem.1817  1
2014 Gan X, Wu L, Huang S, Zhong C, Shi H, Li G, Yu H, Howard Swerdlow R, Xi Chen J, Yan SS. Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction. Free Radical Biology & Medicine. 75: 230-40. PMID 25064321 DOI: 10.1016/J.Freeradbiomed.2014.07.021  0.56
2014 Wilkins HM, Harris JL, Carl SM, E L, Lu J, Eva Selfridge J, Roy N, Hutfles L, Koppel S, Morris J, Burns JM, Michaelis ML, Michaelis EK, Brooks WM, Swerdlow RH. Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis. Human Molecular Genetics. 23: 6528-41. PMID 25027327 DOI: 10.1093/Hmg/Ddu371  1
2014 E L, Burns JM, Swerdlow RH. Effect of high-intensity exercise on aged mouse brain mitochondria, neurogenesis, and inflammation. Neurobiology of Aging. 35: 2574-83. PMID 25002036 DOI: 10.1016/j.neurobiolaging.2014.05.033  1
2014 Esteves AR, Swerdlow RH, Cardoso SM. LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Experimental Neurology. 261: 206-16. PMID 24907399 DOI: 10.1016/J.Expneurol.2014.05.025  1
2014 Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Is Alzheimer's disease a systemic disease? Biochimica Et Biophysica Acta. 1842: 1340-9. PMID 24747741 DOI: 10.1016/J.Bbadis.2014.04.012  1
2014 Tan EP, Villar MT, E L, Lu J, Selfridge JE, Artigues A, Swerdlow RH, Slawson C. Altering O-linked β-N-acetylglucosamine cycling disrupts mitochondrial function. The Journal of Biological Chemistry. 289: 14719-30. PMID 24713701 DOI: 10.1074/jbc.M113.525790  1
2014 Harris JL, Yeh HW, Swerdlow RH, Choi IY, Lee P, Brooks WM. High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging. Neurobiology of Aging. 35: 1686-94. PMID 24559659 DOI: 10.1016/J.Neurobiolaging.2014.01.018  1
2014 Stroh M, Swerdlow RH, Zhu H. Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring. Biochemical Pharmacology. 88: 573-83. PMID 24361914 DOI: 10.1016/J.Bcp.2013.11.022  1
2014 Gan X, Huang S, Wu L, Wang Y, Hu G, Li G, Zhang H, Yu H, Swerdlow RH, Chen JX, Yan SS. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell Biochimica Et Biophysica Acta - Molecular Basis of Disease. 1842: 220-231. PMID 24252614 DOI: 10.1016/J.Bbadis.2013.11.009  1
2014 Dai Y, Zheng K, Clark J, Swerdlow RH, Pulst SM, Sutton JP, Shinobu LA, Simon DK. Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation. Human Molecular Genetics. 23: 637-47. PMID 24101601 DOI: 10.1093/Hmg/Ddt450  1
2014 Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochimica Et Biophysica Acta. 1842: 1219-31. PMID 24071439 DOI: 10.1016/J.Bbadis.2013.09.010  1
2014 Swerdlow RH. Bioenergetic medicine. British Journal of Pharmacology. 171: 1854-69. PMID 24004341 DOI: 10.1111/bph.12394  0.01
2013 Ridge PG, Koop A, Maxwell TJ, Bailey MH, Swerdlow RH, Kauwe JS, Honea RA. Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease. Plos One. 8: e74158. PMID 24040196 DOI: 10.1371/Journal.Pone.0074158  1
2013 E L, Lu J, Selfridge JE, Burns JM, Swerdlow RH. Lactate administration reproduces specific brain and liver exercise-related changes. Journal of Neurochemistry. 127: 91-100. PMID 23927032 DOI: 10.1111/jnc.12394  1
2013 Herrup K, Carrillo MC, Schenk D, Cacace A, Desanti S, Fremeau R, Bhat R, Glicksman M, May P, Swerdlow R, Van Eldik LJ, Bain LJ, Budd S. Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 452-458.e1. PMID 23809366 DOI: 10.1016/J.Jalz.2013.01.017  1
2013 Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Tselis A, Swerdlow RH, Miller BB, et al. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism & Related Disorders. 19: 869-77. PMID 23787135 DOI: 10.1016/J.Parkreldis.2013.05.013  1
2013 Silva DF, Selfridge JE, Lu J, E L, Roy N, Hutfles L, Burns JM, Michaelis EK, Yan S, Cardoso SM, Swerdlow RH. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Human Molecular Genetics. 22: 3931-46. PMID 23740939 DOI: 10.1093/Hmg/Ddt247  1
2013 Uysal U, Seremet S, Lamping JW, Adams JM, Liu DY, Swerdlow RH, Aires DJ. Consumption of polyphenol plants may slow aging and associated diseases. Current Pharmaceutical Design. 19: 6094-111. PMID 23448445 DOI: 10.2174/1381612811319340004  1
2013 Burns JM, Swerdlow RH. Backwaters and rapids on the amyloid river. Neurology. 80: 878-9. PMID 23446682 DOI: 10.1212/Wnl.0B013E3182840D14  1
2013 Swerdlow RH, E L, Aires D, Lu J. Glycolysis-respiration relationships in a neuroblastoma cell line. Biochimica Et Biophysica Acta. 1830: 2891-8. PMID 23313167 DOI: 10.1016/j.bbagen.2013.01.002  1
2013 Lu J, E L, Roy N, Hutfles L, Selfridge E, Funk E, Burns JM, Swerdlow RH. Effect of cholinergic signaling on neuronal cell bioenergetics. Journal of Alzheimer's Disease : Jad. 33: 1135-46. PMID 23099815 DOI: 10.3233/Jad-2012-121822  1
2013 E L, Lu J, Burns JM, Swerdlow RH. Effect of exercise on mouse liver and brain bioenergetic infrastructures. Experimental Physiology. 98: 207-19. PMID 22613742 DOI: 10.1113/expphysiol.2012.066688  1
2013 Selfridge JE, E L, Lu J, Swerdlow RH. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiology of Disease. 51: 3-12. PMID 22266017 DOI: 10.1016/j.nbd.2011.12.057  1
2012 Swerdlow RH, Newell KL. "Untangling" the relationship between Alzheimer disease and dementia with Lewy bodies. Neurology. 79: 1938-9. PMID 23035062 DOI: 10.1212/Wnl.0B013E3182735Ecf  1
2012 Martins-Branco D, Esteves AR, Santos D, Arduino DM, Swerdlow RH, Oliveira CR, Januario C, Cardoso SM. Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness? Experimental Neurology. 238: 89-99. PMID 22921536 DOI: 10.7490/F1000Research.1092129.1  1
2012 Harris JL, Yeh HW, Choi IY, Lee P, Berman NE, Swerdlow RH, Craciunas SC, Brooks WM. Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 2122-34. PMID 22892723 DOI: 10.1038/Jcbfm.2012.114  1
2012 Arduíno DM, Esteves AR, Cortes L, Silva DF, Patel B, Grazina M, Swerdlow RH, Oliveira CR, Cardoso SM. Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic. Human Molecular Genetics. 21: 4680-702. PMID 22843496 DOI: 10.1093/Hmg/Dds309  1
2012 Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology. 79: 566-74. PMID 22843259 DOI: 10.1212/Wnl.0B013E318263575A  1
2012 Silva DF, Selfridge JE, Lu J, E L, Cardoso SM, Swerdlow RH. Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. Advances in Pharmacology (San Diego, Calif.). 64: 83-126. PMID 22840745 DOI: 10.1016/B978-0-12-394816-8.00003-9  1
2012 Swerdlow RH, Corder EH. For Alzheimer disease GWAS, pulling needles from the haystack is just the first step. Neurology. 79: 204-5. PMID 22722635 DOI: 10.1212/Wnl.0B013E318260581D  0.01
2012 Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Maternal family history is associated with Alzheimer's disease biomarkers. Journal of Alzheimer's Disease : Jad. 31: 659-68. PMID 22669011 DOI: 10.3233/Jad-2012-120676  1
2012 Lezi E, Swerdlow RH. Mitochondria in neurodegeneration. Advances in Experimental Medicine and Biology. 942: 269-86. PMID 22399427 DOI: 10.1007/978-94-007-2869-1_12  1
2012 Aires DJ, Rockwell G, Wang T, Frontera J, Wick J, Wang W, Tonkovic-Capin M, Lu J, E L, Zhu H, Swerdlow RH. Potentiation of dietary restriction-induced lifespan extension by polyphenols. Biochimica Et Biophysica Acta. 1822: 522-6. PMID 22265987 DOI: 10.1016/J.Bbadis.2012.01.005  1
2012 Swerdlow RH, Jicha GA. Alzheimer disease: can the exam predict the pathology? Neurology. 78: 374-5. PMID 22238417 DOI: 10.1212/Wnl.0B013E318245F48D  1
2012 Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, ... ... Swerdlow RH, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nature Genetics. 44: 200-5. PMID 22197934 DOI: 10.1038/Ng.1027  1
2012 Swerdlow RH. β-Apptists and Tauists, it is time for a sermon from the book of biogenesis. Journal of Neurochemistry. 120: 347-9. PMID 22035261 DOI: 10.1111/J.1471-4159.2011.07561.X  0.01
2012 Swerdlow RH. Alzheimer's disease pathologic cascades: who comes first, what drives what. Neurotoxicity Research. 22: 182-94. PMID 21913048 DOI: 10.1007/S12640-011-9272-9  0.01
2012 Swerdlow RH. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxidants & Redox Signaling. 16: 1434-55. PMID 21902597 DOI: 10.1089/Ars.2011.4149  0.01
2012 Burns JM, Honea RA, Vidoni ED, Hutfles LJ, Brooks WM, Swerdlow RH. Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging. Biochimica Et Biophysica Acta. 1822: 333-9. PMID 21745566 DOI: 10.1016/J.Bbadis.2011.06.011  1
2012 Vidoni ED, Honea RA, Billinger SA, Swerdlow RH, Burns JM. Cardiorespiratory fitness is associated with atrophy in Alzheimer's and aging over 2 years. Neurobiology of Aging. 33: 1624-32. PMID 21531480 DOI: 10.1016/J.Neurobiolaging.2011.03.016  1
2012 Swerdlow RH. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence. Antioxidants & Redox Signaling. 16: 950-64. PMID 21338319 DOI: 10.1089/Ars.2011.3948  0.01
2011 Simon DK, Chu CT, Swerdlow RH. Mitochondria and Parkinson's disease. Parkinson's Disease. 2011: 261791. PMID 22973533 DOI: 10.4061/2011/261791  1
2011 Swerdlow RH. Brain aging, Alzheimer's disease, and mitochondria. Biochimica Et Biophysica Acta. 1812: 1630-9. PMID 21920438 DOI: 10.1016/J.Bbadis.2011.08.012  0.01
2011 Swerdlow RH. Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases. Current Pharmaceutical Design. 17: 3356-73. PMID 21902672 DOI: 10.2174/138161211798072535  0.01
2011 Honea RA, Swerdlow RH, Vidoni ED, Burns JM. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology. 76: 822-9. PMID 21357834 DOI: 10.1212/Wnl.0B013E31820E7B74  1
2011 Xu M, Wang W, Frontera JR, Neely MC, Lu J, Aires D, Hsu FF, Turk J, Swerdlow RH, Carlson SE, Zhu H. Ncb5or deficiency increases fatty acid catabolism and oxidative stress. The Journal of Biological Chemistry. 286: 11141-54. PMID 21300801 DOI: 10.1074/Jbc.M110.196543  1
2011 Lu J, E L, Wang W, Frontera J, Zhu H, Wang WT, Lee P, Choi IY, Brooks WM, Burns JM, Aires D, Swerdlow RH. Alternate day fasting impacts the brain insulin-signaling pathway of young adult male C57BL/6 mice. Journal of Neurochemistry. 117: 154-63. PMID 21244426 DOI: 10.1111/J.1471-4159.2011.07184.X  1
2010 Onyango IG, Ahn JY, Tuttle JB, Bennett JP, Swerdlow RH. Nerve growth factor attenuates oxidant-induced β-amyloid neurotoxicity in sporadic Alzheimer's disease cybrids. Journal of Neurochemistry. 114: 1605-18. PMID 20561151 DOI: 10.1111/J.1471-4159.2010.06871.X  1
2010 Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, Cardoso SM. Microtubule depolymerization potentiates alpha-synuclein oligomerization. Frontiers in Aging Neuroscience. 1: 5. PMID 20552056 DOI: 10.3389/Neuro.24.005.2009  1
2010 Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis. Journal of Alzheimer's Disease : Jad. 20: S265-79. PMID 20442494 DOI: 10.3233/Jad-2010-100339  1
2010 Lu J, Wang K, Rodova M, Esteves R, Berry D, E L, Crafter A, Barrett M, Cardoso SM, Onyango I, Parker WD, Fontes J, Burns JM, Swerdlow RH. Polymorphic variation in cytochrome oxidase subunit genes. Journal of Alzheimer's Disease : Jad. 21: 141-54. PMID 20413852 DOI: 10.3233/Jad-2010-100123  1
2010 Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Archives of Neurology. 67: 428-33. PMID 20385908 DOI: 10.1001/Archneurol.2010.38  1
2010 Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M. Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Human Genomics. 4: 170-93. PMID 20368139 DOI: 10.1186/1479-7364-4-3-170  1
2010 Swerdlow RH. An Alzheimer disease presenilin mutation, syndrome diversity, and a shrinking world. Neurology. 74: 790-1. PMID 20164096 DOI: 10.1212/Wnl.0B013E3181D3E429  0.01
2010 Esteves AR, Lu J, Rodova M, Onyango I, Lezi E, Dubinsky R, Lyons KE, Pahwa R, Burns JM, Cardoso SM, Swerdlow RH. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. Journal of Neurochemistry. 113: 674-82. PMID 20132468 DOI: 10.1111/J.1471-4159.2010.06631.X  1
2010 Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology. 74: 113-20. PMID 20065246 DOI: 10.1212/Wnl.0B013E3181C918Cb  1
2010 Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, Cardoso SM. Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology. Neurobiology of Disease. 37: 723-30. PMID 20034566 DOI: 10.1016/J.Nbd.2009.12.011  1
2010 Zhang L, Yu C, Vasquez FE, Galeva N, Onyango I, Swerdlow RH, Dobrowsky RT. Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. Journal of Proteome Research. 9: 458-71. PMID 19905032 DOI: 10.1021/Pr900818G  1
2010 Onyango IG, Lu J, Rodova M, Lezi E, Crafter AB, Swerdlow RH. Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochimica Et Biophysica Acta. 1802: 228-34. PMID 19682571 DOI: 10.1016/J.Bbadis.2009.07.014  1
2009 Swerdlow RH. Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies. Pharmaceuticals (Basel, Switzerland). 2: 150-167. PMID 21814473 DOI: 10.3390/Ph2030150  0.01
2009 Swerdlow RH. The neurodegenerative mitochondriopathies. Journal of Alzheimer's Disease : Jad. 17: 737-51. PMID 19542616 DOI: 10.3233/Jad-2009-1095  0.01
2009 Swerdlow RH, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Experimental Neurology. 218: 308-15. PMID 19416677 DOI: 10.1016/J.Expneurol.2009.01.011  1
2009 Guo W, Jiang L, Bhasin S, Khan SM, Swerdlow RH. DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination. Mitochondrion. 9: 261-5. PMID 19324101 DOI: 10.1016/J.Mito.2009.03.003  1
2009 Swerdlow RH, Miller BB, Lopes MB, Mandell JW, Wooten GF, Damgaard P, Manning C, Fowler M, Brashear HR. Autosomal dominant subcortical gliosis presenting as frontotemporal dementia. Neurology. 72: 260-7. PMID 19153373 DOI: 10.1212/01.Wnl.0000339484.61490.A4  1
2009 Gupte AA, Bomhoff GL, Swerdlow RH, Geiger PC. Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes. 58: 567-78. PMID 19073766 DOI: 10.2337/Db08-1070  1
2009 Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, Cardoso SM. Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's disease cybrids. Antioxidants & Redox Signaling. 11: 439-48. PMID 18717628 DOI: 10.1089/Ars.2008.2247  1
2008 Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, Brooks WM, Swerdlow RH. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 71: 210-6. PMID 18625967 DOI: 10.1212/01.Wnl.0000317094.86209.Cb  1
2008 Domingues AF, Arduíno DM, Esteves AR, Swerdlow RH, Oliveira CR, Cardoso SM. Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease. Free Radical Biology & Medicine. 45: 820-5. PMID 18619530 DOI: 10.1016/J.Freeradbiomed.2008.06.007  1
2008 Esteves AR, Domingues AF, Ferreira IL, Januário C, Swerdlow RH, Oliveira CR, Cardoso SM. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion. 8: 219-28. PMID 18495557 DOI: 10.1016/J.Mito.2008.03.004  1
2008 Domingues AF, Esteves AR, Swerdlow RH, Oliveira CR, Cardoso SM. Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cells. Neurotoxicity Research. 13: 31-8. PMID 18367438 DOI: 10.1007/Bf03033365  1
2008 Parker WD, Parks JK, Swerdlow RH. Complex I deficiency in Parkinson's disease frontal cortex. Brain Research. 1189: 215-8. PMID 18061150 DOI: 10.1016/J.Brainres.2007.10.061  1
2008 McAllister J, Ghosh S, Berry D, Park M, Sadeghi S, Wang KX, Parker WD, Swerdlow RH. Effects of memantine on mitochondrial function. Biochemical Pharmacology. 75: 956-64. PMID 18053965 DOI: 10.1016/J.Bcp.2007.10.019  1
2007 Swerdlow RH. Pathogenesis of Alzheimer's disease. Clinical Interventions in Aging. 2: 347-59. PMID 18044185  0.01
2007 Swerdlow RH. PET sheds light on Alzheimer's disease genetic risk. Proceedings of the National Academy of Sciences of the United States of America. 104: 18881-2. PMID 18025455 DOI: 10.1073/Pnas.0709690104  0.01
2007 Swerdlow RH. Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem. Antioxidants & Redox Signaling. 9: 1591-603. PMID 17663643 DOI: 10.1089/Ars.2007.1676  0.01
2007 Ghosh S, Patel N, Rahn D, McAllister J, Sadeghi S, Horwitz G, Berry D, Kai XW, Swerdlow RH. The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells Molecular Pharmacology. 71: 1695-1702. PMID 17387142 DOI: 10.1124/Mol.106.033845  1
2007 Swerdlow RH. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. Journal of Neuroscience Research. 85: 3416-28. PMID 17243174 DOI: 10.1002/Jnr.21167  0.01
2007 Dimberg EL, Crowe SE, Trugman JM, Swerdlow RH, Lopes MB, Bourne TD, Burns TM. Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 407-11. PMID 17230474 DOI: 10.1002/Mds.21324  1
2007 Khan SM, Smigrodzki RM, Swerdlow RH. Cell and animal models of mtDNA biology: progress and prospects. American Journal of Physiology. Cell Physiology. 292: C658-69. PMID 16899549 DOI: 10.1152/Ajpcell.00224.2006  1
2007 Swerdlow RH. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiology of Aging. 28: 1465-80. PMID 16876913 DOI: 10.1016/J.Neurobiolaging.2006.06.021  0.01
2006 Barrett AM, Orange W, Keller M, Damgaard P, Swerdlow RH. Short-term effect of dementia disclosure: how patients and families describe the diagnosis. Journal of the American Geriatrics Society. 54: 1968-70. PMID 17198527 DOI: 10.1111/J.1532-5415.2006.00992.X  1
2006 Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett P. Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 183-93. PMID 16873965 DOI: 10.3233/Jad-2006-9210  1
2006 Swerdlow RH, Weaver B, Grawey A, Wenger C, Freed E, Worrall BB. Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease. Journal of the Neurological Sciences. 247: 224-30. PMID 16784756 DOI: 10.1016/J.Jns.2006.05.053  0.01
2006 Cunha-Oliveira T, Rego AC, Cardoso SM, Borges F, Swerdlow RH, Macedo T, de Oliveira CR. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Research. 1089: 44-54. PMID 16638611 DOI: 10.1016/J.Brainres.2006.03.061  1
2006 Zhang BX, Ma X, Zhang W, Yeh CK, Lin A, Luo J, Sprague EA, Swerdlow RH, Katz MS. Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria. American Journal of Physiology. Cell Physiology. 290: C1321-33. PMID 16601147 DOI: 10.1152/Ajpcell.00335.2005  1
2006 Zhang BX, Ma X, Shu Z, Yeh CK, Swerdlow RH, Katz MS. Differential regulation of intracellular calcium oscillations by mitochondria and gap junctions. Cell Biochemistry and Biophysics. 44: 187-203. PMID 16456221 DOI: 10.1385/Cbb:44:2:187  1
2006 Swerdlow RH, Redpath GT, Binder DR, Davis JN, VandenBerg SR. Mitochondrial DNA depletion analysis by pseudogene ratioing. Journal of Neuroscience Methods. 150: 265-71. PMID 16118020 DOI: 10.1016/J.Jneumeth.2005.06.023  1
2005 Binder DR, Dunn WH, Swerdlow RH. Molecular characterization of mtDNA depleted and repleted NT2 cell lines. Mitochondrion. 5: 255-65. PMID 16050988 DOI: 10.1016/J.Mito.2005.04.003  1
2004 Barrett MJ, Alones V, Wang KX, Phan L, Swerdlow RH. Mitochondria-derived oxidative stress induces a heat shock protein response. Journal of Neuroscience Research. 78: 420-9. PMID 15389841 DOI: 10.1002/Jnr.20249  1
2004 Swerdlow RH, Khan SM. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Medical Hypotheses. 63: 8-20. PMID 15193340 DOI: 10.1016/J.Mehy.2003.12.045  1
2004 Cardoso SM, Santana I, Swerdlow RH, Oliveira CR. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. Journal of Neurochemistry. 89: 1417-26. PMID 15189344 DOI: 10.1111/J.1471-4159.2004.02438.X  1
2004 Trimmer PA, Keeney PM, Borland MK, Simon FA, Almeida J, Swerdlow RH, Parks JP, Parker WD, Bennett JP. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiology of Disease. 15: 29-39. PMID 14751768 DOI: 10.1016/J.Nbd.2003.09.011  1
2004 Swerdlow RH, Juel VC, Wooten GF. Dystonia with and without deafness is caused by TIMM8A mutation. Advances in Neurology. 94: 147-54. PMID 14509668  1
2003 Burns JM, Swerdlow RH. Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign Archives of Neurology. 60: 437-440. PMID 12633158 DOI: 10.1001/Archneur.60.3.437  1
2002 Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. International Review of Neurobiology. 53: 341-85. PMID 12512346 DOI: 10.1016/S0074-7742(02)53013-0  1
2002 Morais Cardoso S, Swerdlow RH, Oliveira CR. Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Research. 931: 117-25. PMID 11897097 DOI: 10.1016/S0006-8993(02)02256-4  1
2002 Swerdlow RH. Mitochondrial DNA--related mitochondrial dysfunction in neurodegenerative diseases. Archives of Pathology & Laboratory Medicine. 126: 271-80. PMID 11860299 DOI: 10.1043/0003-9985(2002)126<0271:Mdrmdi>2.0.Co;2  0.01
2001 Swerdlow RH, Wooten GF. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. Annals of Neurology. 50: 537-40. PMID 11601506 DOI: 10.1002/Ana.1160  1
2001 Currie LJ, Harrison MB, Trugman JM, Bennett JP, Swerdlow RH, Manning CA, Wooten GF. Maternal age is not a risk factor for Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 71: 130-1. PMID 11439965 DOI: 10.1136/jnnp.71.1.130  1
2001 Swerdlow RH, Parks JK, Cassarino DS, Binder DR, Bennett JP, Di Iorio G, Golbe LI, Parker WD. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Experimental Neurology. 169: 479-85. PMID 11358461 DOI: 10.1006/Exnr.2001.7674  1
2001 Swerdlow RH, Parker WD, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Wooten GF. Gender ratio differences between Parkinson's disease patients and their affected relatives. Parkinsonism & Related Disorders. 7: 129-133. PMID 11248594 DOI: 10.1016/S1353-8020(00)00029-8  1
2001 Albers DS, Swerdlow RH, Manfredi G, Gajewski C, Yang L, Parker WD, Beal MF. Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Experimental Neurology. 168: 196-8. PMID 11170735 DOI: 10.1006/Exnr.2000.7607  1
2000 Swerdlow RH, Parks JK, Pattee G, Parker WD. Role of mitochondria in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 1: 185-90. PMID 11464951 DOI: 10.1080/14660820050515179  1
2000 Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP, Wooten GF, Parker WD. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. Journal of Neurochemistry. 75: 1681-4. PMID 10987850 DOI: 10.1046/J.1471-4159.2000.0751681.X  1
2000 Veech GA, Dennis J, Keeney PM, Fall CP, Swerdlow RH, Parker WD, Bennett JP. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. Journal of Neuroscience Research. 61: 693-700. PMID 10972966 DOI: 10.1002/1097-4547(20000915)61:6<693::Aid-Jnr13>3.0.Co;2-4  1
2000 Cassarino DS, Halvorsen EM, Swerdlow RH, Abramova NN, Parker WD, Sturgill TW, Bennett JP. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. Journal of Neurochemistry. 74: 1384-92. PMID 10737593 DOI: 10.1046/J.1471-4159.2000.0741384.X  1
2000 Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP, Miller SW, Davis RE, Parker WD. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Experimental Neurology. 162: 37-50. PMID 10716887 DOI: 10.1006/Exnr.2000.7333  1
1999 Ghosh SS, Swerdlow RH, Miller SW, Sheeman B, Parker WD, Davis RE. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Annals of the New York Academy of Sciences. 893: 176-91. PMID 10672237 DOI: 10.1111/J.1749-6632.1999.Tb07825.X  1
1999 Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD. Mitochondrial abnormalities in non-alcoholic steatohepatitis Journal of Hepatology. 31: 430-434. PMID 10488700 DOI: 10.1016/S0168-8278(99)80033-6  1
1999 Swerdlow RH, Parks JK, Cassarino DS, Shilling AT, Bennett JP, Harrison MB, Parker WD. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Biochemical and Biophysical Research Communications. 261: 701-4. PMID 10441489 DOI: 10.1006/Bbrc.1999.1095  1
1999 McGuffin P, Gottesman II. Risk factors for schizophrenia. The New England Journal of Medicine. 341: 370-1; author reply . PMID 10428662 DOI: 10.1056/NEJM199907293410513  1
1998 Swerdlow RH, Parks JK, Davis JN, Cassarino DS, Trimmer PA, Currie LJ, Dougherty J, Bridges WS, Bennett JP, Wooten GF, Parker WD. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Annals of Neurology. 44: 873-81. PMID 9851431 DOI: 10.1002/Ana.410440605  1
1998 Swerdlow RH, Parks JK, Cassarino DS, Trimmer PA, Miller SW, Maguire DJ, Sheehan JP, Maguire RS, Pattee G, Juel VC, Phillips LH, Tuttle JB, Bennett JP, Davis RE, Parker WD. Mitochondria in sporadic amyotrophic lateral sclerosis. Experimental Neurology. 153: 135-42. PMID 9743575 DOI: 10.1006/Exnr.1998.6866  1
1998 Cassarino DS, Swerdlow RH, Parks JK, Parker WD, Bennett JP. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochemical and Biophysical Research Communications. 248: 168-73. PMID 9675105 DOI: 10.1006/Bbrc.1998.8866  1
1998 Parker WD, Swerdlow RH. Mitochondrial dysfunction in idiopathic Parkinson disease. American Journal of Human Genetics. 62: 758-62. PMID 9529370 DOI: 10.1086/301812  1
1997 Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker WD, Bennett JP. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochimica Et Biophysica Acta. 1362: 77-86. PMID 9434102 DOI: 10.1016/S0925-4439(97)00070-7  1
1997 Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP, Davis RE, Parker WD. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology. 49: 918-25. PMID 9339668 DOI: 10.1212/Wnl.49.4.918  1
1997 Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. Journal of Neurochemistry. 68: 1221-33. PMID 9048769 DOI: 10.1046/J.1471-4159.1997.68031221.X  1
1996 Swerdlow RH, Hanna GR. Behcet's disease: Presentation with sagittal sinus thrombosis diagnosed noninvasively Headache. 36: 115-118. PMID 8742686 DOI: 10.1046/j.1526-4610.1996.3602115.x  1
1994 Smith TS, Swerdlow RH, Parker WD, Bennett JP. Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase. Neuroreport. 5: 2598-600. PMID 7535121 DOI: 10.1097/00001756-199412000-00048  1
Show low-probability matches.